HC Wainwright Lowers Ikena Oncology (NASDAQ:IKNA) Price Target to $11.00
Ikena Oncology (NASDAQ:IKNA – Free Report) had its price objective trimmed by HC Wainwright from $18.00 to $11.00 in a report issued on Thursday, Benzinga reports. The firm currently has a buy rating on the stock. Separately, Wedbush started coverage on shares of Ikena Oncology in a research note on Thursday, September 21st. They issued […]
More Stories
UGI Co. (NYSE:UGI) Shares Purchased by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC raised its position in UGI Co. (NYSE:UGI – Free Report) by 28.4% during the 4th...
Wealth Enhancement Advisory Services LLC Buys 25,545 Shares of Invesco BulletShares 2032 Corporate Bond ETF (NASDAQ:BSCW)
Wealth Enhancement Advisory Services LLC increased its position in shares of Invesco BulletShares 2032 Corporate Bond ETF (NASDAQ:BSCW – Free...
Wealth Enhancement Advisory Services LLC Acquires 1,505 Shares of Duolingo, Inc. (NASDAQ:DUOL)
Wealth Enhancement Advisory Services LLC raised its holdings in shares of Duolingo, Inc. (NASDAQ:DUOL – Free Report) by 74.8% in...
Modine Manufacturing (NYSE:MOD) Shares Purchased by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC increased its stake in shares of Modine Manufacturing (NYSE:MOD – Free Report) by 2.7% during...
Tyson Foods, Inc. (NYSE:TSN) Shares Bought by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC raised its holdings in Tyson Foods, Inc. (NYSE:TSN – Free Report) by 66.8% during the...
Wealth Enhancement Advisory Services LLC Raises Stock Holdings in Cognex Co. (NASDAQ:CGNX)
Wealth Enhancement Advisory Services LLC increased its holdings in shares of Cognex Co. (NASDAQ:CGNX – Free Report) by 56.9% during...